NLC Health Ventures is an internationally leading venture builder and investment fund specializing in health technology. The organization is devoted to revolutionizing patient care by transforming scientific discoveries into viable commercial solutions. As a healthtech venture builder and early-stage investor, NLC Health Ventures bridges the gap between scientific research and market-ready innovations. Every year, NLC assesses about 1,500 inventions, builds over 100 ventures, and impacts more than 247,000 patients. With a team of more than 80 healthcare experts, the organization has successfully raised over €135 million for its ventures. The expertise of NLC Health Ventures spans areas such as cardiovascular healthcare, orthopedics and spine, biotechnology, and general health technology including neonatal and respiratory technologies. Additionally, NLC operates four captive funds to support promising health technology innovations. Their mission is also reflected in their collaborations with esteemed partners like VGZ, Mayo Clinic, and University of Oxford, among others. By resorting to collaborative approaches and leveraging global expert networks, NLC Health Ventures excels in bringing science to life.